Abortion Pill Reversal Legal Claim Analyzer

Evidentiary & Constitutional Inputs

Scientific Falsity / ACOG Rebuttal Weight 75

Strength of medical consensus (ACOG / FDA warnings on safety, unproven clinical trials, progesterone protocols).

Consumer Deception Score (UCL § 17500) 82

Likelihood that reasonable consumers in California are misled regarding guaranteed efficacy or clinical safety.

Commercial Free Speech Protection 40

First Amendment protection asserted: ideological viewpoints, non-misleading clinical claims, or scientific advocacy.

Judicial Injunction Strictness Standard 88

Court inclination toward preliminary state enforcement against deceptive public statements prior to full jury trial.

Legal Principle (Central Hudson Gas & Electric Corp. v. PSC): Misleading or untruthful commercial advertising receives no First Amendment immunity against state deceptive practice statutes.

Judicial Ruling Analysis Live Simulation

Preliminary Injunction Probability

82%

Projected Ruling Outcome

Preliminary Injunction Granted (False Advertising)

The court finds California has established a probability of prevailing under Business & Professions Code § 17500. Commercial speech protections under Central Hudson are unavailing because claims lack FDA-approved randomized trial substantiation.

Primary Legal Test

Central Hudson Commercial Speech & California Business and Professions Code § 17500

First Amendment Exposure

Low (Commercial Speech Subject to State Deception Standards)

California Statutory Risk Tier

Tier 1: High Civil Penalties ($2,500/violation)

Evidentiary Standard Balance

State Rebuttal Dominant (ACOG/FDA Consensus Prevails)